A bionic pancreas for people with diabetes could help keep long-term blood sugar levels lower

Embargoed until: Publicly released: 2022-09-29 07:00

International

Photo by Mykenzie Johnson on Unsplash

A bionic pancreas that automatically delivers insulin to someone with diabetes can reduce glycated hemoglobin levels, a long-term measurement of blood sugar, more than current practices according to international research. The team randomly assigned about 200 adults and children to either receive treatment from a bionic pancreas or standard care over 13 weeks. At the end, the researchers say the glycated hemoglobin levels dropped in the bionic pancreas group but remained steady in the standard care group.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page The URL will go live after the embargo ends

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Massachusetts General Hospital, USA

Funder: Supported by a grant (1UC4DK108612-01) from the National Institute of Diabetes and Digestive and Kidney Diseases, by an investigator-initiated study award from Novo Nordisk, and by Beta Bionics, which also provided the experimental bionic pancreas devices used in the trial.

Media Contact/s

Contact details are only visible to registered journalists.